Cheryl Scott has sold stock and made no open-market buys since May 2017

Cheryl Scott is a corporate director and healthcare executive who has served on the board of Progyny, Inc. since October 2019.( As a director of Progyny, she contributes to the company’s governance and strategic oversight, including equity-related decisions reflected in her recent Form 4 insider trading activity in which she exercised options and sold shares of Progyny stock.( Her board role at Progyny is part of a broader portfolio of governance positions across healthcare and mission‑driven organizations.(

Scott is the Principal of the McClintock Scott Group and previously served as Senior Advisor to the Bill & Melinda Gates Foundation and President and Chief Executive Officer of Group Health Cooperative, where she led the Seattle‑based health system for eight years.( She has held board or leadership roles at Evolent Health, Inc., REI (where she was board chair), Sutter Health, Neurotrack, Living Goods, and other private and non‑profit entities, reflecting extensive experience in healthcare management, corporate governance, and social impact.( Scott holds a B.A. in Journalism and an M.H.A. (Master of Health Administration) from the University of Washington, where she is also a Clinical Professor of Health Services.(

Written by Perplexity from public sources.